Stemedica: Worldwide License for Stem Cell Stabilization Technologies – Drug Discovery & Development
|
Stemedica: Worldwide License for Stem Cell Stabilization Technologies
Drug Discovery & Development "UST's technology immediately accelerates Stemedica's development of a wide range of products containing stem cell factors for consumer and medical markets worldwide," said Nikolai Tankovich, MD, PhD, Stemedica's President and Chief Medical Officer. |
